Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

New treatments for alopecia focus on personalized plans to improve hair regrowth and reduce side effects.

New treatments for hair loss focus on personalized and regenerative approaches for better results.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Adult female acne is complex and requires a combination of treatments for effective management.